PRZOOM - /newswire/ -
Noida, Uttar Pradesh, India, 2010/12/23 - The biopharmaceutical segment is projected to grow at a CAGR of around 12% during FY 2011 - FY 2013, RNCOS identified.
The Indian biotech industry has stupendously grown during the past few years on the back of a large pool of scientific talent, world-class information technology industry, and vibrant pharmaceutical sector. Moreover, our research has found that, among the segments, the biopharma segment constitutes a major part of the total biotech market. The biopharmaceutical segment will be further benefited from the fact that India has the capabilities and requisite talent to become a major supplier of biogeneric to the developed world in coming years. As per our research report “Booming Biotech Market in India”, the biopharmaceutical segment is projected to grow at a CAGR of around 12% during FY 2011 - FY 2013.
Bright prospects of the biopharmaceuticals can be attributed to the growth of vaccine business. We have found that vaccines will retain its position of the largest contributor to the biopharmaceutical market accounting for more than half of the total market in FY 2010. Vaccines were followed by the diagnostics and therapeutics segments. Our research report has analyzed the biopharmaceutical segment and its sub-segments along with their forecasts. Our study has also covered information on major players of the biopharmaceutical segment and its sub-segments.
Besides biopharmaceutical, our report has done an extensive research and analysis of the biotech market together with its other segments. We have also included the future outlook of biotechnology market along with its segments’ future scenarios. In addition, information has been covered on export and domestic consumption and key players in these segments. Various emerging sectors have also been discussed in the report.
Our report has thoroughly examined current market trends; industrial developments and competitive landscape to enable clients understand the market structure and its progress in coming years. Due consideration has been given to the possible aftereffects of recession on the industry, while drafting the report. Moreover, we have discussed factors that are driving the market. Our study has also analyzed the market at regional level. Further, we have discussed biotech funding, government initiatives, regulatory environment, and key players.
RNCOS (rncos.com) specializes in Industry intelligence and creative solutions for contemporary business segments. Our professionals study and analyze the industry and its various components, with comprehensive study of the changing market behavior. Our accuracy and data precision proves beneficial in terms of pricing and time management that assist the consultants in meeting their objectives in a cost-effective and timely manner.